Repositioning Candidates
Repositioning candidates for NAFLD are derived from DrugBank which fall into three categories: therapeutic strategy-associated, target-associated, and indication-associated candidates. For each candidate, detailed properties are extracted from DrugBank, and related strategies, target and NAFLD-associated disease in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
Search for:
hypertensive90 records.
| Candidate ID | Source ID | Source Type | Compound Type | Candidate Name | Inclusion Criteria | |
|---|---|---|---|---|---|---|
| R0064 | DB00177 | approved; investigational | small molecule | Valsartan | Therapeutic strategy associated | Details |
| R0065 | DB00178 | approved | small molecule | Ramipril | Therapeutic strategy associated | Details |
| R0075 | DB00203 | approved; investigational | small molecule | Sildenafil | Indication associated | Details |
| R0077 | DB00206 | approved; investigational | small molecule | Reserpine | Therapeutic strategy associated | Details |
| R0081 | DB00214 | approved | small molecule | Torasemide | Therapeutic strategy associated | Details |
| R0084 | DB00217 | approved | small molecule | Bethanidine | Therapeutic strategy associated | Details |
| R0087 | DB00226 | approved | small molecule | Guanadrel | Indication associated | Details |
| R0090 | DB00232 | withdrawn | small molecule | Methyclothiazide | Therapeutic strategy associated | Details |
| R0098 | DB00264 | approved; investigational | small molecule | Metoprolol | Therapeutic strategy associated | Details |
| R0111 | DB00310 | approved | small molecule | Chlorthalidone | Therapeutic strategy associated | Details |
| R0115 | DB00325 | approved; investigational | small molecule | Nitroprusside | Indication associated | Details |
| R0120 | DB00335 | approved | small molecule | Atenolol | Therapeutic strategy associated | Details |
| R0123 | DB00343 | approved; investigational | small molecule | Diltiazem | Therapeutic strategy associated | Details |
| R0125 | DB00346 | approved; investigational | small molecule | Alfuzosin | Therapeutic strategy associated | Details |
| R0126 | DB00350 | approved; investigational | small molecule | Minoxidil | Therapeutic strategy associated | Details |
| R0137 | DB00381 | approved | small molecule | Amlodipine | Therapeutic strategy associated | Details |
| R0138 | DB00384 | approved | small molecule | Triamterene | Therapeutic strategy associated | Details |
| R0142 | DB00401 | approved | small molecule | Nisoldipine | Indication associated | Details |
| R0145 | DB00436 | approved | small molecule | Bendroflumethiazide | Therapeutic strategy associated | Details |
| R0161 | DB00476 | approved | small molecule | Duloxetine | Therapeutic strategy associated | Details |
| R0170 | DB00492 | approved | small molecule | Fosinopril | Indication associated | Details |
| R0175 | DB00519 | approved | small molecule | Trandolapril | Indication associated | Details |
| R0176 | DB00521 | approved | small molecule | Carteolol | Indication associated | Details |
| R0177 | DB00524 | approved | small molecule | Metolazone | Therapeutic strategy associated | Details |
| R0193 | DB00562 | approved | small molecule | Benzthiazide | Therapeutic strategy associated | Details |
| R0201 | DB00584 | approved; vet_approved | small molecule | Enalapril | Therapeutic strategy associated | Details |
| R0204 | DB00590 | approved | small molecule | Doxazosin | Therapeutic strategy associated | Details |
| R0206 | DB00594 | approved | small molecule | Amiloride | Therapeutic strategy associated | Details |
| R0209 | DB00598 | approved | small molecule | Labetalol | Therapeutic strategy associated | Details |
| R0213 | DB00606 | approved | small molecule | Cyclothiazide | Indication associated | Details |
| R0215 | DB00612 | approved | small molecule | Bisoprolol | Indication associated | Details |
| R0221 | DB00622 | approved; investigational | small molecule | Nicardipine | Indication associated | Details |
| R0230 | DB00657 | approved; investigational | small molecule | Mecamylamine | Therapeutic strategy associated | Details |
| R0231 | DB00661 | approved | small molecule | Verapamil | Therapeutic strategy associated | Details |
| R0241 | DB00692 | approved | small molecule | Phentolamine | Indication associated | Details |
| R0244 | DB00695 | approved; vet_approved | small molecule | Furosemide | Indication associated | Details |
| R0256 | DB00727 | approved; investigational | small molecule | Nitroglycerin | Indication associated | Details |
| R0271 | DB00765 | approved | small molecule | Metyrosine | Therapeutic strategy associated | Details |
| R0276 | DB00774 | approved; investigational; withdrawn | small molecule | Hydroflumethiazide | Indication associated | Details |
| R0280 | DB00785 | approved | small molecule | Cryptenamine | Therapeutic strategy associated | Details |
| R0283 | DB00796 | approved | small molecule | Candesartan cilexetil | Target associated | Details |
| R0284 | DB00800 | approved | small molecule | Fenoldopam | Indication associated | Details |
| R0288 | DB00808 | approved | small molecule | Indapamide | Therapeutic strategy associated | Details |
| R0304 | DB00841 | approved | small molecule | Dobutamine | Therapeutic strategy associated | Details |
| R0314 | DB00866 | experimental; withdrawn | small molecule | Alprenolol | Indication associated | Details |
| R0320 | DB00876 | approved | small molecule | Eprosartan | Target associated | Details |
| R0321 | DB00880 | approved; vet_approved | small molecule | Chlorothiazide | Therapeutic strategy associated | Details |
| R0328 | DB00903 | approved; investigational | small molecule | Etacrynic acid | Therapeutic strategy associated | Details |
| R0348 | DB00968 | approved | small molecule | Methyldopa | Therapeutic strategy associated | Details |
| R0374 | DB01021 | approved; vet_approved | small molecule | Trichlormethiazide | Therapeutic strategy associated | Details |
| R0377 | DB01029 | approved; investigational | small molecule | Irbesartan | Target associated | Details |
| R0387 | DB01054 | approved; investigational | small molecule | Nitrendipine | Indication associated | Details |
| R0397 | DB01089 | approved | small molecule | Deserpidine | Therapeutic strategy associated | Details |
| R0398 | DB01090 | approved | small molecule | Pentolinium | Therapeutic strategy associated | Details |
| R0411 | DB01116 | approved; investigational | small molecule | Trimethaphan | Therapeutic strategy associated | Details |
| R0414 | DB01119 | approved | small molecule | Diazoxide | Indication associated | Details |
| R0433 | DB01170 | approved | small molecule | Guanethidine | Indication associated | Details |
| R0435 | DB01180 | approved | small molecule | Rescinnamine | Indication associated | Details |
| R0451 | DB01214 | approved | small molecule | Metipranolol | Indication associated | Details |
| R0463 | DB01244 | approved; withdrawn | small molecule | Bepridil | Therapeutic strategy associated | Details |
| R0474 | DB01275 | approved | small molecule | Hydralazine | Indication associated | Details |
| R0490 | DB01324 | approved | small molecule | Polythiazide | Therapeutic strategy associated | Details |
| R0491 | DB01325 | approved | small molecule | Quinethazone | Therapeutic strategy associated | Details |
| R0497 | DB01342 | experimental | small molecule | Forasartan | Target associated | Details |
| R0499 | DB01348 | approved | small molecule | Spirapril | Indication associated | Details |
| R0502 | DB01359 | approved; investigational | small molecule | Penbutolol | Indication associated | Details |
| R0545 | DB01612 | approved | small molecule | Amyl Nitrite | Indication associated | Details |
| R0548 | DB01626 | approved | small molecule | Pargyline | Therapeutic strategy associated | Details |
| R0624 | DB04846 | approved; investigational | small molecule | Celiprolol | Therapeutic strategy associated | Details |
| R0648 | DB04920 | approved; investigational | small molecule | Clevidipine | Indication associated | Details |
| R0858 | DB05739 | investigational | biotech | CYT006-AngQb | Therapeutic strategy associated | Details |
| R0951 | DB06237 | approved | small molecule | Avanafil | Therapeutic strategy associated | Details |
| R0987 | DB06345 | investigational | small molecule | AR-9281 | Therapeutic strategy associated | Details |
| R1161 | DB08822 | approved; investigational | small molecule | Azilsartan medoxomil | Target associated | Details |
| R1195 | DB09026 | approved; investigational | small molecule | Aliskiren | Indication associated | Details |
| R1241 | DB09204 | investigational | small molecule | Arotinolol | Therapeutic strategy associated | Details |
| R1252 | DB09227 | experimental | small molecule | Barnidipine | Therapeutic strategy associated | Details |
| R1254 | DB09230 | investigational | small molecule | Azelnidipine | Therapeutic strategy associated | Details |
| R1255 | DB09231 | experimental | small molecule | Benidipine | Indication associated | Details |
| R1257 | DB09235 | experimental | small molecule | Efonidipine | Therapeutic strategy associated | Details |
| R1258 | DB09236 | approved; investigational | small molecule | Lacidipine | Therapeutic strategy associated | Details |
| R1259 | DB09237 | approved; investigational | small molecule | Levamlodipine | Indication associated | Details |
| R1260 | DB09238 | approved; investigational | small molecule | Manidipine | Therapeutic strategy associated | Details |
| R1262 | DB09243 | experimental | small molecule | Hydracarbazine | Indication associated | Details |
| R1280 | DB09279 | investigational | small molecule | Fimasartan | Therapeutic strategy associated | Details |
| R1305 | DB09363 | investigational | small molecule | Rauwolfia serpentina root | Therapeutic strategy associated | Details |
| R1360 | DB11265 | nutraceutical | biotech | Curcuma xanthorrhiza oil | Therapeutic strategy associated | Details |
| R1418 | DB11928 | approved; investigational | biotech | Vosoritide | Therapeutic strategy associated | Details |
| R1427 | DB12007 | experimental | small molecule | Isoflavone | Therapeutic strategy associated | Details |
| R1489 | DB13345 | approved; experimental | small molecule | Dihydroergocristine | Therapeutic strategy associated | Details |